Pure Lab Vitamins
NAC N-ACETYL-CYSTEINE 600mg 120 vegi-caps
NAC N-ACETYL-CYSTEINE 600mg 120 vegi-caps
Couldn't load pickup availability
THE ULTIMATE ANTIOXIDANT
As an antioxidant itself, and a precursor to the most important antioxidant in the body, Glutathione, NAC protects cells from damage caused by the excessive oxidative stress that results from inflammatory states, chronic disease, prolonged strenuous exercise, pollution exposure and generalized stress.
It is well documented that NAC minimizes the liver damage caused by the overuse of certain pharmaceutical drugs and the acute exposures to environmental chemicals. NAC does all this with the help of Selenomethionine, by way of replenishing the body's own antioxidant, glutathione, via the glutathione redox system.
NAC also has the ability to reduce the viscosity of mucus, and stimulates the clearing of mucus from the airways. This makes NAC a valuable component of any respiratory symptom-management program where congestion occurs.
Af the same time, NAC protects the lungs from the damaging effects of inhaled pollutants. NAC supports heart health in a myriad of ways, with the capacity to support healthier homocysteine and lipoprotein A levels, two biomarkers associated with cardiovascular disease when they are elevated.
Conditions that may benefit from NAC supplementation include:
- Asthma
- Chronic bronchitis
- Cystic fibrosis
- Emphysema
- Exposure to pollutants
- Endurance Sports
- Fatty Live Disease
- Heart Disease
- Pharmaceutical use
- Respiratory Congestion
NPN: 80094654
Recommended Use: Source of Antioxidants
Recommended Dose: Adults: Take 1 capsule daily.
Ingredients
Medicinal Ingredients (per capsule): 1N-Acetyl Cysteine 600mg.
Non-Medicinal Ingredients: 100% vegi-caps, Microcrystalline Cellulose, Silicon Dioxide, Magnesium Stearate (Veg. Source).
Contains No: Gluten, wheat, sugar, yeast, milk, egg, shellfish, soy, corn, or preservatives. No artificial colours. Product is vegan and halal.
Risks: Consult a health care practitioner prior to use if you are pregnant, breastfeeding or have kidney stones. Do not use if safety seal is broken.
Contraindications: Do not take this product if you are taking antibiotics or nitroglycerin.
Research
References
Conrad C, Lymp J, Thompson V, et al. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. J Cyst Fibros. 2015;14(2):219-227.
De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J. 1997;10(7):1535-1541.
Dekhuijzen PN, van Beurden WJ. The role for N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(2):99-106.
Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008;8(12):1955-1962.
Gavish D, Breslow JL, Lipoprotein(a) reduction by N-aetylcysteine. Lancet 1991; 337:203-204.
Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008;359(3):285-292.
Khoshbaten M, Aliasgarzadeh A, Masnadi K, et al. N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease. Hepat Mon. 2010;10(1):12-16.
Lee PH, Hong J, Jang AS. N-acetylcysteine decreases airway inflammation and responsiveness in asthma by modulating claudin 18 expression. Korean J Intern Med. 2020;35(5):1229-1237.
Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009;80(3):265-269.
Stey C, Steurer J, Bachmann S, Medici TC, Tramèr MR. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J. 2000;16(2):253-262.
van Zandwijk N. N-acetylcysteine for lung cancer prevention. Chest. 1995 May;107(5):1437-41.
Yilmaz H, Sahin S, Sayar N, et al. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. Acta Cardiol. 2007;62(6):579-585.
Share
